Determination of ticarcillin in human plasma and in urine by reversed-phase LC

1995 ◽  
Vol 13 (2) ◽  
pp. 159-164 ◽  
Author(s):  
Greg La Follette ◽  
Anura L. Jayewardene ◽  
Ananda K. Seneviratne ◽  
Emil T. Lin ◽  
John G. Gambertoglio
Bioanalysis ◽  
2012 ◽  
Vol 4 (24) ◽  
pp. 2909-2927 ◽  
Author(s):  
Primal Sharma ◽  
Swati Guttikar ◽  
Gajendra Solanki ◽  
Daxesh P Patel ◽  
Pranav S Shrivastav

2020 ◽  
Vol 20 (13) ◽  
pp. 1053-1059
Author(s):  
Mahmoud M. Sebaiy ◽  
Noha I. Ziedan

Background: Allergic diseases are considered as the major burden on public health with increased prevalence globally. Histamine H1-receptor antagonists are the foremost commonly used drugs in the treatment of allergic disorders. The target drug in this study, loratadine, belongs to this class of drugs and its biometabolite desloratadine which is also a non-sedating H1 receptor antagonist with anti-histaminic activity being 2.5 to 4 times greater than loratadine. This study aimed to develop and validate a novel isocratic Reversed-phase High-Performance Liquid Chromatography (RP-HPLC) method for rapid and simultaneous separation and determination of loratadine and its metabolite, desloratadine in human plasma. Methods: The drug extraction method from plasma was based on protein precipitation technique. The separation was carried out on a Thermo Scientific BDS Hypersil C18 column (5μm, 250 x 4.60 mm) in a mobile phase of MeOH: 0.025M KH2PO4 adjusted to pH 3.50 using orthophosphoric acid (85: 15, v/v) at an ambient temperature. The flow rate was maintained at 1 mL/min and maximum absorption was measured using the PDA detector at 248 nm. Results: The retention times of loratadine and desloratadine in plasma samples were recorded to be 4.10 and 5.08 minutes, respectively, indicating a short analysis time. Limits of detection were found to be 1.80 and 1.97 ng/mL for loratadine and desloratadine, respectively, showing a high degree of sensitivity of the method. The method was then validated according to FDA guidelines for the determination of the two analytes in human plasma. Conclusion: The results obtained indicate that the proposed method is rapid, sensitive in the nanogram range, accurate, selective, robust and reproducible compared to other reported methods.


1994 ◽  
Vol 77 (6) ◽  
pp. 1654-1659 ◽  
Author(s):  
Mjn Zhou ◽  
Gui-Yun Li ◽  
Stephanie A Whalen

Abstract Metsulfuron methyl, its hydroxy metabolite (A1), and its glucose conjugate metabolite (A) were determined in several crops by liquid chromatography (LC) using a simple extraction and cleanup scheme. After the parent and 2 major metabolites were extracted from crops with methanol, metabolite A was enzymatically hydrolyzed to metabolite A1 with β-glucosidase. The treated extracts were cleaned up chromatographically, and then metsulfuron methyl and metabolite A1 were quantitatively determined by reversed-phase LC with UV detection at 254 nm. Recovery of metsulfuron methyl and its 2 metabolites was 90 ± 6% over a range of 0.005 to 0.4 ppm from fortified samples of brown grain, wheat, barley, sugarcane stalk, and oat straw. Method detection limits (MDLs) were 0.005 ppm for metsulfuron methyl, 0.006 ppm for metabolite A, and 0.003 ppm for metabolite A1 in such crops as brown grain, wheat, barley, and sugarcane, and 0.01 ppm for metsulfuron methyl, 0.015 ppm for metabolite A, and 0.01 ppm for metabolite A1 in oat straw. The MDLs were estimated on the basis of a signal-to-noise ratio of 5 within a confidence interval of 95%. The method has potential application for the analyses of these analytes in other crops and feeds and may be applicable to other sulfonylurea herbicides.


2020 ◽  
Vol 183 ◽  
pp. 113147 ◽  
Author(s):  
Yuning Zhang ◽  
Yashpal S. Chhonker ◽  
Veenu Bala ◽  
Alex Hagg ◽  
Linda G. Snetselaar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document